Archive - June 2023
New approach in cancer therapy with innovative mechanism-of-action for ferroptosis induction
FDA Approves Roctavian (valoctocogene roxaparvovec-rvox) Gene Therapy for Adults with Severe Hemophilia A
Proteins predict significant step toward development of diabetes
FDA Approves Lantidra (donislecel-jujn) Cellular Therapy to Treat Patients with Type 1 Diabetes
FDA Approves Ngenla (somatrogon-ghla) Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone Deficiency
Bayer's new pharmaceutical R&D strategy to accelerate breakthrough innovations
FDA Approves Rystiggo (rozanolixizumab-noli) for the Treatment of Adults with Generalized Myasthenia Gravis
FDA accepts Pfizer's application for hemophilia B gene therapy fidanacogene elaparvovec